Challenges in treatment of patients with non-classic congenital adrenal hyperplasia

Challenges in treatment of patients with non-classic congenital adrenal hyperplasia

Congenital adrenal hyperplasia (CAH) due to 21α-hydroxylase deficiency (21OHD) or 11β-hydroxylase deficiency (11OHD) are congenital conditions with affected adrenal steroidogenesis. Patients with classic 21OHD and 11OHD have a (nearly) complete enzyme deficiency resulting in impaired cortisol synthe...

Full description

Bibliographic Details
Main Authors: Bas P. H. Adriaansen, Mariska A. M. Schröder, Paul N. Span, Fred C. G. J. Sweep, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Endocrinology
Subjects:
Non-classic congenital adrenal hyperplasia (NCCAH)
21-hydroxylase deficiency (21OHD)
11-hydroxylase deficiency (11OHD)
treatment options
glucocorticoid treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1064024/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.1064024/full

Similar Items